Seegene Establish French Subsidiary to Expand European Footprint
05 Dec 2025 //
PR NEWSWIRE
Microbix & Seegene Mexico Collaborate To Improve Test Accuracy
03 Dec 2025 //
GLOBENEWSWIRE
OPEN Healthcare Unveils Innovative Lab & Home Testing
25 Sep 2025 //
PHARMAWEB
Seegene, Springer Nature Launch 2025-26 Impact Grant Applications
02 Sep 2025 //
PR NEWSWIRE
Seegene Launches Cureca and StAgora at ADLM 2025 Diagnostics Meet
06 Aug 2025 //
PR NEWSWIRE
Seegene Launches First Unattended PCR Automation at ADLM 2025
24 Jul 2025 //
PR NEWSWIRE
Seegene Unveils STAgora, Infectious Disease Analytics Platform
01 Jul 2025 //
PR NEWSWIRE
Seegene`s CURECA(TM) Potential Game Changer in PCR Automation
05 May 2025 //
PR NEWSWIRE
Seegene Unveils HPV Genotyping Solution at EUROGIN 2025
20 Mar 2025 //
PR NEWSWIRE
Seegene Hosts Roundtable with Microsoft and Springer Nature
28 Oct 2024 //
PR NEWSWIRE
Seegene Hosts Roundtable With Microsoft And Springer Nature
24 Oct 2024 //
PR NEWSWIRE
Seegene And Werfen Finalize Partnership Agreement on Technology
08 Oct 2024 //
PR NEWSWIRE
Seegene Expands Mpox RUO Product Line With Enhanced Detection Assays
09 Sep 2024 //
PR NEWSWIRE
Seegene And Springer Nature Launch `Nature Awards MDx Impact Grants`
02 Sep 2024 //
PR NEWSWIRE
Seegene Develops Mpox PCR Test Following WHO Emergency Declaration
26 Aug 2024 //
PR NEWSWIRE
Seegene Showcased its Multiplex Technology at ADLM 2024
05 Aug 2024 //
PR NEWSWIRE
Seegene and Springer Nature Announce Strategic Alliance
16 May 2024 //
PR NEWSWIRE
Korea`s Seegene announces strategic alliance with Springer Nature
16 May 2024 //
BIOSPECTRUM ASIA
Seegene & UK Health Security "a World Free from All Diseases"
08 Apr 2024 //
PR NEWSWIRE
Seegene and Springer Nature Announce Awardees for the Open Innovation Program
15 Mar 2024 //
PR NEWSWIRE
Seegene Announces Collaboration with Microsoft
24 Jan 2024 //
PR NEWSWIRE
Seegene obtains ISO45001 certification
27 Dec 2023 //
PR NEWSWIRE
Seegene Earns ESG Rating from the Korea Institute of Corporate Governance
10 Nov 2023 //
PR NEWSWIRE
Seegene Reinforces Commitment to Strong ESG Management
18 Oct 2023 //
PR NEWSWIRE
Seegene Unveils Open Innovation Program Powered by Seegene with Springer Nature
04 Sep 2023 //
PR NEWSWIRE
Seegene unveils solutions to popularize molecular diagnostics at 2023 AACC
31 Jul 2023 //
PR NEWSWIRE
Seegene Obtains IVDR Certification for 30 Diagnostic Assays
01 Jun 2023 //
PR NEWSWIRE
Seegene declares to share Syndromic PCR technologies to prevent future pandemics
28 Mar 2023 //
PR NEWSWIRE
Seegene unveils strategies for global expansion at 2022 AACC
29 Jul 2022 //
PRNEWSWIRE
Seegene launches world`s first In-life PCR campaign in Vietnam
19 Jul 2022 //
PRNEWSWIRE
Seegene to pave way for PCR testing at clinics with EU-approved multiplex test
29 Jun 2022 //
PRNEWSWIRE
Seegene develops PCR test to detect monkeypox virus
28 Jun 2022 //
PRNEWSWIRE
Seegene unveils `$12 PCR testing` initiative to help end COVID-19 pandemic
25 May 2022 //
PRNEWSWIRE
Seegene reports first quarter 2022 financial results
13 May 2022 //
PRNEWSWIRE
Korean MDx Seegene`s Allplex RV Master Assay approved in Australia
07 Apr 2022 //
BIOSPECTRUMASIA
Seegene`s Allplex RV Master Assay receives TGA approval, European CE-IVD mark
06 Apr 2022 //
PRNEWSWIRE
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary
17 Mar 2022 //
PRNEWSWIRE
Seegene appoints Richard Creager as CEO of U.S. subsidiary
02 Mar 2022 //
PRNEWSWIRE
Seegene unveils new assay optimized for on-site testing Covid era
24 Feb 2022 //
PRNEWSWIRE
Seegene Announces Q4 and Full-Year 2021 Financial Results
17 Feb 2022 //
PRNEWSWIRE
Korean startup Seegene inks supply deal of 4 M COVID-19 tests with Brazil
11 Feb 2022 //
BIOSPECTRUMASIA
Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil
10 Feb 2022 //
PRNEWSWIRE

Market Place
Sourcing Support